WallStreetZenWallStreetZen

NASDAQ: ABMD
Abiomed Inc Stock

Open Broker Account
$378.22+1.02 (+0.27%)
Updated Dec 5, 2022
ABMD Price
$378.22
Fair Value Price
$382.21
Market Cap
$17.05B
52 Week Low
$219.85
52 Week High
$381.99
P/E
64.43x
P/B
11.08x
P/S
10.38x
PEG
13.49x
Dividend Yield
N/A
Revenue
$1.07B
Earnings
$266.76M
Gross Margin
81.3%
Operating Margin
31.76%
Profit Margin
24.8%
Debt to Equity
0.1
Operating Cash Flow
$251M
Beta
0.96
Next Earnings
Feb 1, 2023
Ex-Dividend
N/A
Next Dividend
N/A

ABMD Overview

Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by interventional cardiologists to support patients in the cath lab, as well as by cardiac surgeons in the heart surgery suite. It also provides Impella 5.0, Impella LD, and Impella 5.5, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; Impella Connect, a cloud-based technology that enables secure and remote viewing of the automated impella controller for physicians and hospital staffs; and OXY-1 System, a portable external respiratory assistance device. In addition, the company is developing Impella ECP, a pump for blood flow of greater than three liters per minute; Impella XR Sheath, a sheath that expands and recoils allowing small bore access and closure with Impella heart pumps; Impella BTR, a percutaneous micro heart pump with integrated motors and sensors; and preCARDIA, a catheter-mounted superior vena cava therapy system designed to rapidly treat acutely decompensated heart failure. Abiomed, Inc. sells its products through direct sales and clinical support personnel in the Germany, France, United States, Japan, Europe, Canada, Latin America, the Asia-Pacific, and the Middle East. The company was founded in 1981 and is headquartered in Danvers, Massachusetts.

Zen Score

Industry Average (32)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ABMD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ABMD ($378.22) is undervalued by 1.04% relative to our estimate of its Fair Value price of $382.21 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
ABMD ($378.22) is not significantly undervalued (1.04%) relative to our estimate of its Fair Value price of $382.21 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ABMD ($378.22) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ABMD due diligence checks available for Premium users.

Be the first to know about important ABMD news, forecast changes, insider trades & much more!

ABMD News

Valuation

ABMD fair value

Fair Value of ABMD stock based on Discounted Cash Flow (DCF)
Price
$378.22
Fair Value
$382.21
Undervalued by
1.04%
ABMD ($378.22) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ABMD ($378.22) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ABMD ($378.22) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ABMD price to earnings (PE)

For valuing profitable companies with steady earnings
Company
64.43x
Industry
62.76x
Market
21.63x
ABMD is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ABMD is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

ABMD price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
11.08x
Industry
3.76x
ABMD is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ABMD price to earnings growth (PEG)

For valuing profitable companies with growth potential
ABMD is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

ABMD's financial health

Profit margin

Revenue
$265.9M
Net Income
$106.1M
Profit Margin
39.9%
ABMD's Earnings (EBIT) of $341.16M... subscribe to Premium to read more.
Interest Coverage Financials
ABMD's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$1.7B
Liabilities
$156.8M
Debt to equity
0.1
ABMD's short-term assets ($1.06B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ABMD's short-term assets ($1.06B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ABMD's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ABMD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$13.4M
Investing
$101.6M
Financing
-$110.2M
ABMD's operating cash flow ($250.98M)... subscribe to Premium to read more.
Debt Coverage Financials

ABMD vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
ABMD$17.05B+0.27%64.43x11.08x
ALGN$14.68B-5.29%28.91x3.97x
PODD$21.00B-1.83%1,209.72x49.07x
BIO$12.10B-3.17%-2.01x1.43x
SNN$11.85B-1.51%23.65x2.20x

Abiomed Stock FAQ

What is Abiomed's quote symbol?

NASDAQ: ABMD) Abiomed trades on the NASDAQ under the ticker symbol ABMD. Abiomed stock quotes can also be displayed as NASDAQ: ABMD.

If you're new to stock investing, here's how to buy Abiomed stock.

What is the 52 week high and low for Abiomed (NASDAQ: ABMD)?

(NASDAQ: ABMD) Abiomed's 52-week high was $381.99, and its 52-week low was $219.85. It is currently -0.99% from its 52-week high and 72.04% from its 52-week low.

How much is Abiomed stock worth today?

(NASDAQ: ABMD) Abiomed currently has 45,091,184 outstanding shares. With Abiomed stock trading at $378.22 per share, the total value of Abiomed stock (market capitalization) is $17.05B.

Abiomed stock was originally listed at a price of $8.19 in Dec 31, 1997. If you had invested in Abiomed stock at $8.19, your return over the last 24 years would have been 4,518.07%, for an annualized return of 17.31% (not including any dividends or dividend reinvestments).

How much is Abiomed's stock price per share?

(NASDAQ: ABMD) Abiomed stock price per share is $378.22 today (as of Dec 5, 2022).

What is Abiomed's Market Cap?

(NASDAQ: ABMD) Abiomed's market cap is $17.05B, as of Dec 6, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Abiomed's market cap is calculated by multiplying ABMD's current stock price of $378.22 by ABMD's total outstanding shares of 45,091,184.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.